StockData
IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

INVO Fertility, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.60+0.04 (+7.78%)

Close on Oct 19, 2026

Market cap
$1.56M
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
5.2%
0M of 3M shares
Institutional holders
9
8 new, 5 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $6

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Greenblock Capital, LLC617,9549.99%13G (passive)Jun 25, 2025
Steven Boyd371,5629.99%13G (passive) amendmentMar 31, 2026
Ashkan Mapar272,2499.99%13G (passive)Aug 4, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IVFValueChange% of portfolio
Virtu Financial LLC63,1742.52%$120New0.00%
Scientech Research LLC32,3381.29%$61.44KNew0.05%
StoneX Group Inc.15,7020.63%$29.82KNew0.00%
Susquehanna International Group, Llp11,4630.46%$21.78KNew0.00%
Tower Research Capital LLC (TRC)8,1550.33%$15.49KNew0.00%
SBI Securities Co., Ltd.530.00%$101+500.00%
Caitong International Asset Management Co., Ltd380.00%$72New0.00%
Integrated Wealth Concepts LLC80.00%$15New0.00%
Danske Bank A/S10.00%$2New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202690M5.2%8 / 10 / 50M0M
Q1 202660M7.7%6 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of IVFValue% of fundAs of
Fidelity Extended Market Index Fund14,0820.56%$26.47K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-400-0.02%-$760-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Steve ShumChief Executive Officer, Director6740.03%Oct 3, 2025
Terah Renee KrigsvoldChief Financial Officer10.00%Jan 13, 2026
Andrea GorenChief Financial Officer129,2275.15%Aug 28, 2025
Matthew K. SzotDirector0–Dec 5, 2025
Trent D. DavisDirector490.00%Aug 28, 2025
Barbara RyanDirector460.00%Aug 28, 2025
Rebecca MessinaDirector330.00%Aug 28, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Matthew K. Szot
Director
Dec 4, 2025Other−3––0
Matthew K. Szot
Director
Dec 3, 2025Sale−4$1.52$63
Trent D. Davis
Director
Jun 1, 2022Buy+11,184$0.95$10.62K33,622
Barbara Ryan
Director
Jun 1, 2022Buy+10,526$0.95$10.00K22,991
Michael Jos. Campbell
Chief Operating Officer, Director
Jun 1, 2022Buy+10,526$0.95$10.00K75,762
Matthew K. Szot
Director
Jun 1, 2022Buy+14,474$0.95$13.75K39,175
Kevin Doody
Medical Director
Jun 1, 2022Buy−177,306$0.95$168.44K0
Rebecca Messina
Director
Jun 1, 2022Buy+9,868$0.95$9.37K23,045
Andrea Goren
Chief Financial Officer
Jun 1, 2022Buy+52,632$0.95$50.00K129,015
Jeffrey Segal
Director
Jun 1, 2022Buy+9,211$0.95$8.75K28,220
Steve Shum
Chief Executive Officer, Director
Jun 1, 2022Buy+58,885$0.95$55.94K128,420
Barbara Ryan
Director
Jan 15, 2022Award+8,588––21,053
Kevin Doody
Medical Director
Jan 15, 2022Award+7,480––177,306
Michael Jos. Campbell
Chief Operating Officer, Director
Jan 15, 2022Award+15,236––65,236
Trent D. Davis
Director
Jan 15, 2022Award+8,865––22,438
Jeffrey Segal
Director
Jan 15, 2022Award+8,034––18,009
Rebecca Messina
Director
Jan 15, 2022Award+8,311––13,177
Andrea Goren
Chief Financial Officer
Jan 15, 2022Award+5,361––17,861
Matthew K. Szot
Director
Jan 15, 2022Award+10,250––24,701
Steve Shum
Chief Executive Officer, Director
Jan 15, 2022Award+20,111––82,035
Andrea Goren
Chief Financial Officer
Oct 5, 2021Buy+30,674$3.26$100.00K76,383
Steve Shum
Chief Executive Officer, Director
Oct 5, 2021Buy+30,674$3.26$100.00K61,924
Rebecca Messina
Director
May 11, 2021Award+4,806––4,806
AWM Investment Company, Inc.
10% owner
May 10, 2021Buy+1,000$3.76$3.76K1,159,075
AWM Investment Company, Inc.
10% owner
May 6, 2021Buy+1,000$3.85$3.85K1,158,075
AWM Investment Company, Inc.
10% owner
May 4, 2021Buy+2,457$3.85$9.46K1,157,075
AWM Investment Company, Inc.
10% owner
May 4, 2021Buy+465$3.85$1.79K1,154,618
AWM Investment Company, Inc.
10% owner
Apr 27, 2021Buy+3,800$4.44$16.87K1,154,153
AWM Investment Company, Inc.
10% owner
Apr 20, 2021Buy+3,500$3.90$13.65K1,150,353
AWM Investment Company, Inc.
10% owner
Apr 19, 2021Buy+5,801$3.64$21.12K1,146,853
AWM Investment Company, Inc.
10% owner
Apr 16, 2021Buy+9,001$3.83$34.47K1,141,052
AWM Investment Company, Inc.
10% owner
Apr 15, 2021Buy+322$3.85$1.24K1,132,051
AWM Investment Company, Inc.
10% owner
Apr 14, 2021Buy+17,152$3.95$67.75K1,131,729
AWM Investment Company, Inc.
10% owner
Apr 13, 2021Buy+5,800$3.97$23.03K1,114,577
AWM Investment Company, Inc.
10% owner
Apr 12, 2021Buy+13,146$4.00$52.58K1,108,777
AWM Investment Company, Inc.
10% owner
Apr 9, 2021Buy+27,811$4.08$113.47K1,095,631
AWM Investment Company, Inc.
10% owner
Apr 8, 2021Buy+15,000$4.08$61.20K1,067,820
Trent D. Davis
Director
Dec 31, 2020Award+10,475––13,573
Matthew K. Szot
Director
Dec 31, 2020Award+12,112––14,451
Barbara Ryan
Director
Dec 31, 2020Award+10,148––12,465
Kevin Doody
Medical Director
Dec 31, 2020Award+8,184––169,821
Jeffrey Segal
Director
Dec 31, 2020Award+8,838––9,975
Barbara Ryan
Director
Nov 27, 2020Award+2,317––2,317
Jeffrey Segal
Director
Nov 27, 2020Award+1,137––1,137
Matthew K. Szot
Director
Nov 27, 2020Award+2,339––2,339
Michael Jos. Campbell
Chief Operating Officer, Director
Jan 17, 2020Award+1,000,000––1,607,800
Steve Shum
Chief Executive Officer, Director
Oct 16, 2019Award+400,000––1,000,000
Claude Ranoux
10% owner
Dec 3, 2018Discretionary−1,000,000––25,194,000
Claude Ranoux
10% owner
Dec 3, 2018Sale−500,000$0.05$25.00K24,694,000
Claude Ranoux
10% owner
Dec 3, 2018Discretionary−1,000,000––25,194,000
Claude Ranoux
10% owner
Dec 3, 2018Sale−500,000$0.05$25.00K24,694,000
Claude Ranoux
10% owner
Oct 31, 2018Award+910,878––26,194,000
Michael Jos. Campbell
Director
Oct 31, 2018Award+400,000$0.39$156.00K607,800
Kathleen t. Karloff
Chairwoman and CEO, Director
Oct 31, 2018Award+1,040,183$0.39$405.67K13,200,183
Steve Shum
Director
Oct 31, 2018Award+400,000$0.39$156.00K600,000
Robert Joseph Bowdring Jr
Director
Oct 31, 2018Award+1,015,942$0.39$396.22K11,715,942
Claude Ranoux
10% owner
Oct 31, 2018Award+910,878$0.39$355.24K26,194,000
Claude Ranoux
10% owner
Mar 5, 2018Sale−12,642$0.19$2.40K25,283,122
Claude Ranoux
10% owner
Mar 5, 2018Sale−12,642$0.19$2.40K25,283,122
Claude Ranoux
10% owner
Feb 28, 2018Sale−2,000$0.18$36025,296,764

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.